Literature DB >> 25874472

[Plastic surgery of extended defects after exenteration of the pelvis].

A Abdou1, H Bruns1, A Troja1, D Antolovic1, L Li1, H-R Raab1.   

Abstract

Extended resections of pelvic malignancies, especially in cases of recurrent malignancies, result in the formation of large tissue defects in the region of the pelvic floor and perineum, which are difficult to deal with. Both after extra levator rectal excision and pelvic exenteration, wound healing deficiencies and local infections of the perineal wound are frequent. Primary closure is often impossible due to a lack of tissue substance after resection and an additional previous radiotherapy in most cases. This can result in poor or non-healing wounds, a consecutive need of complex care and an increased risk of secondary problems including tumour recurrences. A permanent wound closure of good quality can therefore only be achieved by plastic surgery. This can be done by local or distant muscle flaps with or without skin, for example, the gluteus maximus flap, the vertical rectus abdominis muscle flap (VRAM) or free flaps such as the latissimus dorsi flap. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2015        PMID: 25874472     DOI: 10.1055/s-0035-1545809

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  2 in total

1.  Free latissimus dorsi myocutaneous flap for pelvic floor reconstruction following pelvic exenteration.

Authors:  Ahmed Hossamedine Abdou; Lei Li; Karl Khatib-Chahidi; Achim Troja; Phillip Looft; Eva Monika Gudewer; Hans-Rudolf Raab; Dalibor Antolovic
Journal:  Int J Colorectal Dis       Date:  2015-09-26       Impact factor: 2.571

2.  Interdisciplinary Surgical Approaches in Vaginal and Perineal Reconstruction of Advanced Rectal and Anal Female Cancer Patients.

Authors:  Raymund E Horch; Ingo Ludolph; Aijia Cai; Klaus Weber; Robert Grützmann; Andreas Arkudas
Journal:  Front Oncol       Date:  2020-05-13       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.